Skip to content
10-Q

Quarterly Report

SANGUI BIOTECH INTERNATIONAL INC

0001551163-20-000092

← back to feed
Filed
Nov 13, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2021 · Nov 13, 2020 203.3M sh
Short Term Debt Q1 2021 · Sep 30, 2020 $679.48K
Short Term Debt Q1 2021 · Jun 30, 2020 $618.57K
Stockholders Equity Q1 2021 · Sep 30, 2020 −$158.22K
Stockholders Equity Q1 2021 · Jun 30, 2020 −$82.9K
Current Liabilities Q1 2021 · Sep 30, 2020 $891.71K
Current Liabilities Q1 2021 · Jun 30, 2020 $791.49K
Total Liabilities Q1 2021 · Sep 30, 2020 $955.07K
Total Liabilities Q1 2021 · Jun 30, 2020 $855.21K
Current Assets Q1 2021 · Sep 30, 2020 $65.98K
Current Assets Q1 2021 · Jun 30, 2020 $48.7K
Total Assets Q1 2021 · Sep 30, 2020 $148.77K
Total Assets Q1 2021 · Jun 30, 2020 $125.33K
Operating Cash Flow Q1 2021 · Sep 30, 2019 −$31.26K
Cash And Equivalents Q1 2021 · Sep 30, 2019 $20.59K
Cash And Equivalents Q1 2021 · Jun 30, 2019 $27.45K
Sga Expense Q1 2021 · Sep 30, 2019 $12.19K
Rd Expense Q1 2021 · Sep 30, 2019 $2.24K
Net Income Q1 2021 · Sep 30, 2019 −$42.75K
Operating Income Q1 2021 · Sep 30, 2019 −$55.9K
Gross Profit Q1 2021 · Sep 30, 2019 $282
Revenue Q1 2021 · Sep 30, 2019 $282